Cholesterol recognition sequence

Details for Australian Patent Application No. 2004235618 (hide)

Owner Georgetown University Medical Center

Inventors Hua, Li; Papadopoulos, Vassilios

Agent Watermark

Pub. Number AU-A-2004235618

Parent 776298

Filing date 2 December 2004

Wipo publication date 6 January 2005

Acceptance publication date 11 October 2007

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

C12N 015/82 Mutation or genetic engineering - for plant cells

Event Publications

16 December 2004 Complete Application Filed

6 January 2005 Application Open to Public Inspection

  Published as AU-A-2004235618

11 October 2007 Application Accepted

  Published as AU-A-2004235618

6 December 2007 Assignment before Grant

  Georgetown University Medical Center The application has been assigned to Georgetown University

7 February 2008 Standard Patent Sealed

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235619-Method and device for minimally invasive implantation of biomaterial

2004235617-Lipoxin compounds and their use